Ron Smith, PhD
Principal of Pharmawyze, LLC
Pharmawyze, LLC
Peter Åhnblad, Medical Doctor, Senior Consultant Physician Ear-Nose-Throat
Chief Medical Officer, Head of Board, co-inventor, co-owner
Hogne AB
Nacka, Sweden
Derek Richards
Director of Business Development CRDO
Seqens
Newburyport, Massachusetts, United States
Joel Hellrup, PhD (he/him/his)
Head of Pharmaceutical R&D
Nanexa AB
Uppsala, Uppsala Lan, Sweden
Ruth Schmid, PhD (she/her/hers)
Strategic and Scientific Advisor
NaDeNo
Tiller, Norway
Dan O’Connor, Sr. (Me!)
Senior Director Business Development
Simulations Plus, Inc.
Newtown CT, Connecticut, United States
Rob Sterling
Director, Business Development
Sever Pharma Solutions
Putnam, Connecticut, United States
Katelyn E. Swindle-Reilly, PhD (she/her/hers)
Chief Technology Officer / Associate Professor, Biomedical Engineering, Chemical & Biomolecular Engineering
Vitranu / The Ohio State University
Columbus, Ohio, United States
Daniel Treffer, PhD (he/him/his)
CEO
MeltPrep
Graz, Austria
Nick Gaddum, PhD
Chief Scientific Officer
DEC Healthcare
Nicholas DiFranco, MEM
Global Market Segment Manager - Oral Drug Delivery
Lubrizol Life Science Health
Cleveland, Ohio, United States
Benjamin Winkeljann, PhD (he/him/his)
CEO
RNhale
Munich, Bayern, Germany
Mark Ruane (he/him/his)
Western Regional Sales
SPECTRADYNE LLC
Signal Hill, California, United States
Andrew G. Clark, PhD (he/him/his)
Associate Director of Pharmaceutical Sciences
DigiM Solution
Woburn, Massachusetts, United States
Robert Bloder
Board of Directors, Member and Chief Business Officer
Ascendia Pharmaceuticals
North Brunswick, New Jersey, United States
Michiel van Alst, MSc
CEO
IamFluidics